CURRENT EUROPEAN FUNDINGS
Project Title:
Promotion of the product brand “Gofarm Medical Devices” in international markets in the years 2025–2027.
Project Objective:
The objective of the project is to promote the Gofarm Medical Devices product brand in the markets of Europe and Brazil through the acquisition of new business partners, and thus increase export sales. As a result of the project implementation, by 2029 it is planned to conclude 4 new commercial contracts and increase revenues from exports of the products covered by the project.
Project Description, Planned Activities:
The project involves comprehensive promotion of the Gofarm Medical Devices product brand in international markets — in Europe and Brazil — in the years 2025–2027. It is implemented under the action Promotion of the Brand of Innovative SMEs (FENG 2.25) in the pharmaceutical and medical devices sector.
Within the project, the company will promote its products as an exhibitor at CPhI 2025 in Germany and at the subsequent editions of CPhI 2026 and 2027 held in Europe, as well as at the Medica 2026 trade fair. The project also includes the organization of business missions — to The Pharmacy Show 2025 conference in the United Kingdom, to Raucon conferences in 2026 and 2027 in Portugal, to the Pharma Synergy OTC 2025 conference in Italy and the 2026 edition in one of the cities in Europe, to the Pharma Venue 2026 conference in Spain, and to the FCE Pharma 2026 trade fair in Brazil. In addition, the company plans to conduct a promotional campaign associated with participation in the CPhI Europe 2026 trade fair as part of the project.
Target Group:
The target groups of the project activities are the European and Brazilian markets. The project is addressed to: distributors and importers of medical devices, pharmacy chains and pharmaceutical companies, and business partners seeking ready-made product lines for implementation under private label.
Effects, Project Results:
The implementation of the project will contribute to the conclusion of 4 international commercial contracts by 2029, an increase in export revenues by PLN 800,000 (including PLN 200,000 in 2028 and PLN 600,000 in 2029), expansion of the base of business partners in the European and Brazilian markets, and increased recognition of the Gofarm Medical Devices brand at key industry events.
Project value: PLN 1,427,766.44
European Funds contribution: PLN 649,794.81
Project implementation period: 1 July 2025 – 31 December 2027.
#FunduszeUE #FunduszeEuropejskie
#EUFunds #EuropeanFunds
Project Title
Development of the research and development potential of Gofarm Sp. z o.o. Sp. komandytowa for the purpose of expanding its activities to include the development and production of medicinal products.
Project Objective
The objective of the project is to develop the research and development potential of Gofarm Sp. z o.o. Sp. komandytowa in order to expand the company’s activities into a new area, namely the development and formulation of medicinal products.
Project Description, Planned Activities
The project assumes the development of the company’s research and development potential through the purchase of research equipment enabling the conduct of R&D activities in the field of developing concepts and formulations of new medicines. Within the framework of the project, equipment will be purchased for the creation of a research and development laboratory for solid and liquid formulations of medicinal products, as well as for the creation of an analytical laboratory for testing medicinal products.
Target Group
The planned research activities are intended to respond to the existing supply barrier on the market to date, and the planned product in liquid form will constitute a product innovation at least on a national scale. The project is addressed to: patients suffering from sinusitis, children (an innovative alcohol-free syrup), external entities commissioning the development of medicinal products, and research staff – as the project provides for the creation of new jobs.
Effects, Project Results
The planned result of the project is the establishment of a laboratory together with the necessary R&D infrastructure required for the development and formulation of medicines. Development of a medicinal product supporting the treatment of acute and chronic sinusitis in two dosage forms: coated tablets and syrup. Additional expected effects include: increased competitiveness of the company also in foreign markets, the possibility of providing external services, creation of new jobs for a technologist and an analytical specialist, and increased competitiveness of the Małopolska region. The project will contribute to increasing the supply of new solutions supporting the transformation of the economy towards Industry 4.0.
Project value: PLN 3,265,635.00
European Funds contribution: PLN 1,826,676.00
Project implementation period: from 1 July 2024 to 30 June 2026.
#FunduszeUE #FunduszeEuropejskie
#EUFunds #EuropeanFunds
Project Title
Purchase of R&D services and pro-innovation services for the design and development of a new innovative product by Gofarm Sp. z o.o. Sp. komandytowa.
Project Objective
The objective of the project is to launch a new, innovative product – a reflux gel – addressing the growing social needs resulting from the increasing prevalence of gastroesophageal reflux disease (GERD) in developed countries.
Project Description and Planned Activities
The project involves the procurement of research and development (R&D) and pro-innovation services to implement an innovative, experimental product – a reflux gel.
This product is a medical device with both therapeutic and preventive properties.
As part of the project, the product will undergo toxicity validation (as part of the R&D phase), followed by certification (as part of pro-innovation activities) to enable its market launch. By contracting both services, the company will be able to effectively introduce the product to the market, achieve product innovation, launch a new line of gastroenterological products, and ultimately increase revenue and its share in the medical device market.
Target Group
The target group includes patients struggling with gastroesophageal reflux disease (end users: adults and children over 12 years of age) seeking safe and effective supportive and protective therapies. The target group also includes pharmacy and drugstore chains (business partners) interested in including an innovative medical device in their private label portfolio.
Project Outcomes and Results
The implementation of the project will allow for the launch of a product with a unique formula. The product will be offered under a private label model, which is a novelty in this market segment, enabling business partners to integrate a modern medical device into their own brand portfolios.
- Project Value: PLN 204 303,00
- European Funds Contribution: PLN 141 185, 00
- Project Duration: January 9, 2024 – January 8, 2025
#EUFunds #EuropeanFunds
Any suspicion of non-compliance of the project or the Beneficiary’s activities with the Charter of Fundamental Rights (CFR) or the Convention on the Rights of Persons with Disabilities (CRPD) may be reported to the Managing Authority via email at KPP_KPON@umwm.malopolska.pl or in another format if required by the specific communication needs of the whistleblower. A detailed description of the procedure for reporting non-compliance with CFR/CRPD is available on the FEM program website.
2018/2019 FUNDING
Gofarm Sp. z o.o. Sp. k. received funding from the European Union in the amount of PLN 423,450, which constitutes 75% of eligible expenses for participation in the project:
Development of export activity of Gofarm Sp. z o.o. Sp. k. through promotion on international markets.
Financial assistance is provided under Sub-measure 3.3.3. of the Smart Growth Operational Programme: Support for SMEs in the promotion of product brands – Go to Brand.
The activities planned by Gofarm cover the period from May 2018 to December 2019.
The aim of the project is primarily to develop GOFARM’s export activity by acquiring new business partners, and thus increase export sales. The company will strive to strengthen its position on foreign markets, to establish and develop relationships with business partners and increase sales, which will also directly translate into an increase in the company’s competitiveness and to build a positive image of the company.
Project description:
The GOFARM export development project is being implemented as part of the Biotechnology and Pharmaceuticals Industry Promotion Program, which is an integral part of Sub-measure 3.3.3. Support for SMEs in the promotion of product brands – Go to Brand (POIR).
As part of the project, GOFARM will promote its products at the following events:
– CPhI Worldwide 2018 (Madrid) and 2019 (Frankfurt),
– Middle East Pharma Cold Chain Congress 2019 (Dubai, UAE),
– IPhEB Russia 2019 (St. Petersburg, Russia).
The promotional activities will be additionally complemented by an individual economic mission to the United Arab Emirates and Russia. In addition, the company will benefit from consulting and training services, which will allow it to acquire the knowledge necessary for effective foreign expansion.
Additionally, Gofarm carries out promotional activities: production and distribution of information and promotional materials such as gadgets, printed materials (folders, leaflets, business cards), as well as conducting information and promotional activities in electronic media (positioning of the company’s website) and preparation of the website in Russian.
2020 FUNDING
Gofarm Sp. z o.o. Sp. k. received funding from the European Union in the amount of PLN 198,900, which constitutes 75% of eligible expenses for participation in the project:
Development of export activity of Gofarm Sp. z o.o. Sp. k. through promotion on international markets.
Financial assistance is provided under Sub-measure 3.3.3. of the Smart Growth Operational Program: Support for SMEs in the promotion of product brands – Go to Brand.
The activities planned by Gofarm cover the period from August to December 2020.
The aim of the project is primarily to develop GOFARM’s export activity by acquiring new business partners, and thus increase export sales. The company will strive to strengthen its position on foreign markets, to establish and develop relationships with business partners and increase sales,
which will also directly translate into an increase in the company’s competitiveness and to build a positive image of the company.
Project description:
The GOFARM export activity development project is implemented as part of the Biotechnology and Pharmaceuticals Industry Promotion Program, which is an integral part of Sub-measure 3.3.3. Support for SMEs in the promotion of product brands – Go to Brand (POIR).
As part of the project, GOFARM will promote its products during the following events:
– participation in an outbound mission to the Medipharm 2020 trade fair (Vietnam)
– participation as an exhibitor in the CPhI Worldwide 2020 trade fair (Milan)
– participation in an outbound mission to the CPhI Worldwide 2020 trade fair (Milan)
Additionally, Gofarm carries out promotional activities: production and distribution of information and promotional materials such as gadgets, printed materials (folders, advertising bags), as well as preparation of a film promoting the company’s products and services